Prostate Cancer TPP Communication & Message Testing
Study Details
Business Objective
To validate and optimize messaging that effectively communicate the prostate cancer therapy’s value proposition, ensuring stakeholder alignment and maximizing adoption potential in the oncology market in US and Canada.
Research Objective
Assess how well each creative message aligns with the TPP.
Measure the influence of each message on oncologists’ likelihood to prescribe compared to current standards of care.
Use ranking methodologies to identify top-performing messages and relative importance.
Optimize overall communication strategy and identify bundles representing major categories.
Uncover potential misinterpretations, credibility gaps, or resistance points that could weaken communication effectiveness.
Methodology
Approach
25 minute online quantitative survey.
Respondents
Medical and Radiation Oncologists, Urologists and oncology nurses.
Project Outcomes
What the research delivered
The client leveraged insights into which messages most influence oncologists’ prescribing decisions compared to existing prostate cancer treatments to evaluate resonance with target stakeholders.
The client also used the analysis around which message bundles (efficacy, safety, dosing, convenience, patient outcomes) resonate most strongly with stakeholders to refine their communication strategies ahead of market entry.